ConductScience.org, home

Paper41004342

GATA2 decommissioning of enhancers: A mechanism to constrain inflammatory signaling.

Jung MM and 6 others. Cell Rep, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. GATA2 decommissioning of enhancers: A mechanism to constrain inflammatory signaling. Papers, record 41004342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41004342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
GATA2 decommissioning of enhancers: A mechanism to constrain inflammatory signaling.
PubMed
Journal
Cell Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-10-06
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jung MMMabel M
2Tran VLVu L
3Xiong YYue
4Johnson KDKirby D
5Katsumura KRKoichi R
6Liu PPeng
7Bresnick EHEmery H

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GATA2 Transcription FactorMajor topic
Signal TransductionMajor topic
Enhancer Elements, GeneticMajor topic
InflammationMajor topic
Animals
Mice
Chromatin
Cytokine Receptor gp130
Interleukin-6
Mice, Inbred C57BL
Trans-Activators
Hematopoietic Stem Cells
Proto-Oncogene Proteins
Humans
Receptors, Interleukin-6

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA014520NCI NIH HHSUnited StatesP30CA014520PubMed and NIHNIH RePORTER
F31 DK138794NIDDK NIH HHSUnited StatesF31DK138794PubMed and NIHNIH RePORTER
T32 HL007899NHLBI NIH HHSUnited StatesT32HL007899PubMed and NIHNIH RePORTER
R01 DK068634NIDDK NIH HHSUnited StatesR01DK068634PubMed and NIHNIH RePORTER
U01 CA257666NCI NIH HHSUnited StatesU01CA257666PubMedNIH RePORTER

Download CSV of grants

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18156996Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells.EMBO J1994https://conductscience.org/library/papers/8156996PubMed
214749363Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression.Mol Cell Biol2004https://conductscience.org/library/papers/14749363PubMed
331324781Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.Nat Commun2019https://conductscience.org/library/papers/31324781PubMed
437756546Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice.Blood Adv2023https://conductscience.org/library/papers/37756546PubMed
516861236Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1.J Biol Chem2006https://conductscience.org/library/papers/16861236PubMed
624899309Pro-resolving lipid mediators are leads for resolution physiology.Nature2014https://conductscience.org/library/papers/24899309PubMed
78552649Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8552649PubMed
830707109Transcription factor mutations as a cause of familial myeloid neoplasms.J Clin Invest2019https://conductscience.org/library/papers/30707109PubMed
938422019Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38422019PubMed
1032736380Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories.J Exp Med2020https://conductscience.org/library/papers/32736380PubMed
1124227816GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.Blood2014https://conductscience.org/library/papers/24227816PubMed
1211997509Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.Mol Cell Biol2002https://conductscience.org/library/papers/11997509PubMed
1318779319Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis.Mol Cell Biol2008https://conductscience.org/library/papers/18779319PubMed
1416980610Distinct functions of dispersed GATA factor complexes at an endogenous gene locus.Mol Cell Biol2006https://conductscience.org/library/papers/16980610PubMed
1511689697Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases.Mol Cell Biol2001https://conductscience.org/library/papers/11689697PubMed
1639294495Pharmacological restriction of genomic binding sites redirects PU.1 pioneer transcription factor activity.Nat Genet2024https://conductscience.org/library/papers/39294495PubMed
179326224Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation.Blood1997https://conductscience.org/library/papers/9326224PubMed
1825992861Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity.Immunity2015https://conductscience.org/library/papers/25992861PubMed
1911101873IL-6 switches the differentiation of monocytes from dendritic cells to macrophages.Nat Immunol2000https://conductscience.org/library/papers/11101873PubMed
2010207073CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites.Mol Cell Biol1999https://conductscience.org/library/papers/10207073PubMed

See all 82 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42801378The Runx1-Gata2 axis: epigenetic architecture of lineage fate.Mol Biol Rep2026https://conductscience.org/library/papers/42801378PubMed
42118696MLL3 and MLL4 sustain hematopoietic stem cell multipotency by opposing a B-cell default state.Blood2026https://conductscience.org/library/papers/42118696PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE288701

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41004342

GET https://conductscience.org/api/papers/v1/41004342/references?page=2